LAS VEGAS, Nev., Apr 04, 2017 (SEND2PRESS NEWSWIRE) -- C Diff Foundation's 5th Annual International C.diff. Awareness Conference and Health EXPO will be hosted in Las Vegas, Nev. on November 9 & 10, 2017 at UNLV-Thomas and Mack Center. A panel of C. diff. survivors will join world-renowned experts delivering presentations on health care topics pertaining to the most common pathogen identified, a leading healthcare-associated infection (HAI) in U.S. hospitals alone: Clostridium difficile (C.diff.).
Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released February 2015 by the Centers for Disease Control and Prevention (CDC). About 15,000 deaths were estimated to be directly attributable to C. diff. infections.
Previous studies indicate that C. diff. has become the most common microbial cause of healthcare-associated infections found in U.S. hospitals driving up costs to $4.8 billion each year.
Bringing medical professional guest speakers together, such as Dale Gerding, MD, FACP, FIDSA, Conference Chair and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois and Research Physician at the Edward Hines Jr. VA Hospital, with internationally recognized experts on healthcare-associated infections and the prevention of antimicrobial resistance - provides an educational opportunity for healthcare professionals and those sharing common interests. Presentations will be focused on, but not limited to Clostridium difficile (C.diff.) Prevention, Treatments, Diagnostics, Research, Clinical trials, Microbiome research, Infection Prevention, Irritable Bowel Syndrome treatments and clinical trials, Environmental Safety, Fecal Microbiota Restoration, Antibiotic Stewardship.
The 5th Annual International C.diff. Awareness Conference and Health EXPO will commence on November 9 & 10, 2017, Thomas and Mack Center, UNLV. Shuttle service provided for guests of Embassy Suites Convention Center Hotel, 3600 Paradise Road, Las Vegas, NV 89169 (Hotel Phone: 1 - (702)-947-7156).
The C Diff Foundation is grateful for its alliances; the corporations and organizations in alignment with their mission who join them in raising C. diff. awareness worldwide. A sincere thank you to the Sponsors and Exhibitors of the 5th Annual International C. diff. Awareness Conference and Health EXPO: Diamond Sponsor: Synthetic Biologics.
Gold Sponsors: Clorox Healthcare, Seres Therapeutics, ROCHE, Rebiotix, Nestle Health Science, Xenex. Silver Sponsors: SporeGen, Tru-D. This conference is supported through an educational grant from Sanofi Pasteur US.
Additional information and registration - Early Bird Registration Through June 1:
https://cdifffoundation.org/registration/
"None of us can do this alone, All of us can do this together," says Nancy C. Caralla.
About the C Diff Foundation:
The C Diff Foundation, a 501(c)(3) established 2012, comprised of 100% volunteering professionals dedicated at supporting public health through education and advocating for C. difficile infection (CDI) prevention, treatments, environmental safety, and support worldwide. The Foundress, Nancy C. Caralla, a Nurse diagnosed and treated for Clostridium difficile (C. diff.) infections and witnessing the loss of her father to C. difficile infection involvement, Nancy recognized the need for greater awareness through education, about research being conducted by the government, industry, and academia and better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this devastating, life-threatening infection.
More information: https://cdifffoundation.org/
Media Contact: ncaralla@cdifffoundation.org
News Source: C Diff Foundation
This press release was issued on behalf of the news source, who is solely responsible for its accuracy, by Send2Press Newswire. To view the original story, visit: https://www.send2press.com/wire/international-healthcare-experts-gather-nov-9-10-in-las-vegas-to-discuss-global-problems-around-leading-healthcare-acquired-infection-clostridium-difficile/